R&D in Meat-Processing Technology, Novel Production Methods and Health-Related Areas
First written in FY2017-Q1. 14 of 22 entries say "Restated". Latest entry: FY2026.
4 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「At the Osaka-Kansai Expo, held from April to October 2025, the company exhibited actual cultured meat produced using 3D bioprinting technology by the consortium, as well as a meat maker concept model, in the “Mirai City” area of the Osaka Healthcare Pavilion.」
The company has advanced its R&D policies toward activities aimed at the social implementation of cultured meat, including an exhibition of 3D bioprinting technology for cultured meat. - FY2025AdvancedAnnual report
「“Enhancing the value of safety and taste” and “creating new value toward the realization of sustainability” as the two pillars」
The company organized its R&D policies around two pillars, safety and taste and sustainability, and specified research into microbial identification, the effective use of livestock by-products and microorganisms, functional materials and cultured meat. R&D expenses were ¥1,644 million. - FY2025-H1RestatedAnnual report
「The amount spent on R&D activities by the group as a whole during the current interim consolidated accounting period was ¥844 million. There were no material changes in the group’s R&D activities during the current interim consolidated accounting period.」
The company states that there were no material changes in R&D activities and discloses R&D expenses of ¥844 million for the current interim consolidated accounting period. - FY2023AdvancedAnnual report
「In February 2023, the company established the “Collaborative Research Chair for the Social Implementation of Cultured Meat” at Osaka University’s Suita Campus, in collaboration with Osaka University and others, and began joint research into cultured-meat production using 3D bioprinting technology.」
In addition to its existing research into quality and processing technologies, the company began joint research with universities on the social implementation of cultured meat. - FY2023-Q3RestatedAnnual report
「The amount spent on R&D activities by the group as a whole during the current third quarter of the cumulative consolidated period was ¥1,138 million. There were no material changes in the group’s R&D activities during the current third quarter of the cumulative consolidated period.」
The company confirms that there were no material changes in R&D activities and discloses R&D expenses of ¥1,138 million for the third quarter of the cumulative period. - FY2023-Q2RestatedAnnual report
「The amount spent on R&D activities by the group as a whole during the current second quarter of the cumulative consolidated period was ¥764 million. There were no material changes in the group’s R&D activities during the current second quarter of the cumulative consolidated period.」
The company confirms that there were no material changes in R&D activities and discloses R&D expenses of ¥764 million for the second quarter of the cumulative period. - FY2023-Q1RestatedAnnual report
「The amount spent on R&D activities by the group as a whole during the current first quarter of the cumulative consolidated period was ¥396 million. There were no material changes in the group’s R&D activities during the current first quarter of the cumulative consolidated period.」
The company states that there were no material changes in R&D activities and discloses R&D expenses of ¥396 million for the first quarter of the cumulative period. - FY2022AdvancedAnnual report
「“Advancing shelf-life and quality-preservation technology,” “pursuing greater taste and quality” and “developing basic technologies that address new needs”」
The company expanded its existing R&D policies into specific research themes, including microbial testing, allergen analysis, quality evaluation models, and food-loss and greenhouse-gas reduction, and recorded R&D expenses of ¥1,525 million. - FY2022-Q2RestatedAnnual report
「The amount spent on R&D activities by the group as a whole during the current second quarter of the cumulative consolidated period was ¥735 million. There were no material changes in the group’s R&D activities during the current second quarter of the cumulative consolidated period.」
The company states that there were no material changes in R&D activities and discloses R&D expenses of ¥735 million for the second quarter of the cumulative period. - FY2022-Q1RestatedAnnual report
「The amount spent on R&D activities by the group as a whole during the current first quarter of the cumulative consolidated period was ¥387 million. There were no material changes in the group’s R&D activities during the current first quarter of the cumulative consolidated period.」
The company states that there were no material changes in R&D activities and discloses R&D expenses of ¥387 million for the first quarter of the cumulative period. - FY2021-Q3RestatedAnnual report
「The amount spent on R&D activities by the group as a whole during the current third quarter of the cumulative consolidated period was ¥1,123 million. There were no material changes in the group’s R&D activities during the current third quarter of the cumulative consolidated period.」
The company states that there were no material changes in R&D activities and discloses R&D expenses of ¥1,123 million for the third quarter of the cumulative period. - FY2021-Q2RestatedAnnual report
「The amount spent on R&D activities by the group as a whole during the current second quarter of the cumulative consolidated period was ¥734 million. There were no material changes in the group’s R&D activities during the current second quarter of the cumulative consolidated period.」
The company states that there were no material changes in R&D activities and discloses R&D expenses of ¥734 million for the second quarter of the cumulative period. - FY2020AdvancedAnnual report
「The company is also actively pursuing the development of soy-meat products, which it announced to the media in October last year.」
In addition to its existing research into shelf life, taste and basic technologies, the company identifies the development of soy-meat products as a new R&D theme. - FY2019RestatedAnnual report
「In research activities, the Central Research Institute is pursuing research themes from the perspectives of “advancing shelf-life and quality-preservation technology,” “pursuing greater taste and quality” and “developing basic technologies that address new needs.”」
Against the backdrop of appointing an executive officer responsible for R&D and a group R&D head and integrating both companies’ research functions, the company describes the Central Research Institute’s research themes in concrete terms. - FY2019-Q3RestatedAnnual report
「In addition, the Central Research Institute, which had previously conducted basic research at 伊藤ハム株式会社, and the research functions of 米久株式会社 were transferred to and integrated into the company as organizations directly overseen by the group R&D head.」
The company continues to describe the transfer and integration of both companies’ research functions into the company and the R&D structure centered on the group R&D head. - FY2019-Q2RestatedAnnual report
「Beginning with the first quarter of the cumulative consolidated period, the company established an executive officer responsible for overseeing the R&D function in order to utilize its technologies and product-development expertise throughout the group. It also appointed a group R&D head under that officer to address issues with greater speed. In addition, the Central Research Institute, which had previously conducted basic research at 伊藤ハム株式会社, and the research functions of 米久株式会社 were transferred to and integrated into the company as organizations directly overseen by the group R&D head.」
The company continues to describe the appointment of an executive officer responsible for R&D and a group R&D head, as well as the transfer and integration of both companies’ research functions. - FY2019-Q1AdvancedAnnual report
「Beginning with the current first quarter of the cumulative consolidated period, the company established an executive officer responsible for overseeing the R&D function in order to utilize its technologies and product-development expertise throughout the group. It also appointed a group R&D head under that officer to address issues with greater speed. In addition, the Central Research Institute, which had previously conducted basic research at 伊藤ハム株式会社, and the research functions of 米久株式会社 were transferred to and integrated into the company as organizations directly overseen by the group R&D head.」
The company describes specific progress in its R&D structure, including the establishment of an executive officer responsible for R&D and a group R&D head, and the transfer and integration of the Central Research Institute of 伊藤ハム and the research functions of 米久 into the company. - FY2018AdvancedAnnual report
「The company confirmed the usefulness of the “strain typing method.” Although there are limitations depending on the microbial species, this enables a response with a finer mesh for microbial identification.」
The company confirmed the usefulness of the strain typing method for shelf-life and quality-preservation technology, raising the level of microbial testing. It is also advancing research into salt-reduction technology, softness and ease of swallowing, and the addition of functional ingredients. - FY2017RestatedAnnual report
「In basic research, the company’s core policies are to strengthen meat-processing technology, develop original new production methods and contribute to human health through food.」
The company reiterates meat-processing technology, new production methods and contributions to health as its basic research policies. - FY2017-Q3RestatedAnnual report
「In basic research, the company’s core policies are to strengthen meat-processing technology, develop original new production methods and contribute to human health through food. It is also expanding its analytical testing and sensory evaluation systems for food safety, and making effective use of them in designing new products and making proposals to customers.」
The company continues to describe its existing basic research policies and the expansion of its analytical testing and sensory evaluation systems. - FY2017-Q2RestatedAnnual report
「In basic research, the company’s core policies are to strengthen meat-processing technology, develop original new production methods and contribute to human health through food. It is also expanding its analytical testing and sensory evaluation systems for food safety, and making effective use of them in designing new products and making proposals to customers.」
The company reiterates its existing basic research policies and refers to expanding its analytical testing and sensory evaluation systems. - FY2017-Q1First statedAnnual report
「In basic research, the company’s core policies are to strengthen meat-processing technology, develop original new production methods and contribute to human health through food.」
The company identifies processing technology, new production methods and contributions to health as its basic research and development policies.